Primitive Neuroectodermal Tumor: Clinical Trials

1 trial for Primitive Neuroectodermal Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Primitive Neuroectodermal Tumor: new trials by email Literature Review of Primitive Neuroectodermal Tumor trials Research Report on Primitive Neuroectodermal Tumor

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors
Carboplatin, Mannitol, Melphalan - Central Nervous System Embryonal Neoplasm, Embryonal Tumor With Multilayered Rosettes, C19MC-Altered
Phase 1 / Phase 2UnknownOHSU Knight Cancer Institute172009-07-092021-10-26

Narrower conditions

Medulloblastoma (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neuroectodermal Tumors, Primitive (1)

Broader conditions

Glioma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors (1)

Interventions

Carboplatin (1)  ·  Mannitol (1)  ·  Melphalan (1)  ·  sodium thiosulfate (1)

Sponsors

OHSU Knight Cancer Institute (1)

Countries

United States (1)

Top investigators

Edward A Neuwelt (1)

NIH funding

R01NS044687 (1)